These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4906539)

  • 21. Status and perspectives in chemotherapy of Hodgkin's disease.
    Frei E
    Arch Intern Med; 1973 Mar; 131(3):439-45. PubMed ID: 4739436
    [No Abstract]   [Full Text] [Related]  

  • 22. METHODOLOGY OF PRELIMINARY CHEMOTHERAPEUTIC TRIALS IN PATIENTS WITH MALIGNANT SOLID TUMORS.
    BRINDLEY CO
    Cancer Chemother Rep; 1963 Oct; 32():27-33. PubMed ID: 14088833
    [No Abstract]   [Full Text] [Related]  

  • 23. LONG TERM RESULTS ACHIEVED WITH THE USE OF ALKYLATING AGENTS IN MALIGNANT LYMPHOMA AND HODGKIN'S DISEASE.
    PAPAC RJ; WOOD DA
    Acta Unio Int Contra Cancrum; 1964; 20():377-9. PubMed ID: 14151934
    [No Abstract]   [Full Text] [Related]  

  • 24. [Mitomycin alone and in therapeutic association in the palliative treatment of solid tumors].
    Gary-Bobo J
    J Radiol Electrol Med Nucl; 1971 Dec; 52(12):858-62. PubMed ID: 4113798
    [No Abstract]   [Full Text] [Related]  

  • 25. [Clinical experiences with the cytostatic drug natulan].
    Kohout J
    Med Klin; 1969 May; 64(19):898-901. PubMed ID: 5819002
    [No Abstract]   [Full Text] [Related]  

  • 26. Treatment of Hodgkin's disease and other cancers with 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962).
    Marsh JC; DeConti RC; Hubbard SP
    Cancer Chemother Rep; 1971 Dec; 55(5):599-606. PubMed ID: 4334161
    [No Abstract]   [Full Text] [Related]  

  • 27. THE MALIGNANT LYMPHOMAS.
    MOLANDER DW
    Am J Nurs; 1963 Oct; 63():110-2. PubMed ID: 14045204
    [No Abstract]   [Full Text] [Related]  

  • 28. [HISTOPATHOLOGICAL EFFECTS OF ANTINEOPLASTIC AGENTS ON MALIGNANT LYMPHOMA].
    TANIDA T
    Nagasaki Igakkai Zasshi; 1964 Mar; 39():136-44. PubMed ID: 14143219
    [No Abstract]   [Full Text] [Related]  

  • 29. Vinblastine sulfate vs cyclophosphamide in the therapy for lymphoma.
    Stutzman L; Ezdinli EZ; Stutzman MA
    JAMA; 1966 Jan; 195(3):173-8. PubMed ID: 5322863
    [No Abstract]   [Full Text] [Related]  

  • 30. REPORT ON TWENTY PATIENTS WITH MALIGNANT DISEASE TREATED WITH CYTOTOXIC AGENTS.
    HUMPHRIES SV
    S Afr Med J; 1964 Apr; 38():276-8. PubMed ID: 14147352
    [No Abstract]   [Full Text] [Related]  

  • 31. [The role of vinblastine in the treatment of malignant lymphomas].
    Eridani S; Esposito R; Ponti GB; Giangrande A
    Cancro; 1968; 21():Suppl 6:102+. PubMed ID: 4906143
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical trials with BCNU (NSC-409962) in malignant lymphomas by the Eastern Cooperative Oncology Group.
    Bennett JM; Bakemeier RF; Carbone PP; Ezdinli E; Lenhard RE
    Cancer Treat Rep; 1976 Jun; 60(6):739-45. PubMed ID: 60176
    [No Abstract]   [Full Text] [Related]  

  • 33. THE MANAGEMENT OF LEUKEMIA AND LYMPHOMA.
    HUTCHISON JL
    Appl Ther; 1964 Jul; 6():591-2. PubMed ID: 14179434
    [No Abstract]   [Full Text] [Related]  

  • 34. Treatment of Hodgkin's disease and other malignant lymphomas.
    Aungst CW
    J Surg Oncol; 1973 Jun; 5(6):575-9. PubMed ID: 4589653
    [No Abstract]   [Full Text] [Related]  

  • 35. Endotoxin stimulation in patients with lymphoma: correlation with the myelosuppressive effects of alkylating agents.
    DeConti RC; Kaplan SR; Calabresi P
    Blood; 1972 May; 39(5):602-9. PubMed ID: 5067305
    [No Abstract]   [Full Text] [Related]  

  • 36. Updated Hodgkin's disease. C. Advanced disease and special problems. Comment: the non-Hodgkin's lymphomas.
    Rubin P
    JAMA; 1973 Jan; 223(2):175-8. PubMed ID: 4569818
    [No Abstract]   [Full Text] [Related]  

  • 37. [Vincaleukoblastine in the therapy of malignant neoplasms].
    Rotolo V
    Friuli Med; 1968; 23(1):31-52. PubMed ID: 4910040
    [No Abstract]   [Full Text] [Related]  

  • 38. [Association of intralymphatic radiotherapy and alkylating agents in the treatment of retroperitoneal hematosarcomas].
    Bonadonna G; Chiappa S; Di Pietro S; Marano O; Molinari R; Uslenghi C
    Nouv Rev Fr Hematol; 1967; 7(3):381-92. PubMed ID: 4229322
    [No Abstract]   [Full Text] [Related]  

  • 39. [Experiences with intense cytostatic therapy of malignant tumors].
    Siering H; Reinhardt M
    Arzneimittelforschung; 1968 Sep; 18(9):1182-91. PubMed ID: 4885374
    [No Abstract]   [Full Text] [Related]  

  • 40. [High-dose chemotherapy in nonhematologic tumors].
    Espinosa Arranz E; González Barón M
    Rev Clin Esp; 2001 Feb; 201(2):93-4. PubMed ID: 11345614
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.